LBA5 A phase III trial with a 2x2 factorial design in men with de novo metastatic castration-sensitive prostate cancer: Overall survival with abiraterone acetate plus prednisone in PEACE-1
| Autor: | Fizazi, K., Carles Galceran, J., Foulon, S., Roubaud, G., McDermott, R., Fléchon, A., Tombal, B., Supiot, S., Berthold, D.R., Ronchin, P., Kacso, G., Gravis Mescam, G., Calabro', F., Berdah, J.F., Hasbini, A., Silva, M., Thiery-Vuillemin, A., Latorzeff, I., Rieger, I., Bossi, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1299-S1299 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|